Pulmonary inflammatory myofibroblastic tumor versus IgG4-related inflammatory pseudotumor: differential diagnosis based on a case series

被引:21
|
作者
Zhu, Longfei [1 ]
Li, Jian [1 ]
Liu, Chengwu [1 ]
Ding, Wenshuang [2 ]
Lin, Feng [1 ]
Guo, Chenglin [1 ]
Liu, Lunxu [1 ]
机构
[1] Sichuan Univ, Dept Thorac Surg, West China Hosp, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Peoples R China
关键词
Inflammatory myofibroblastic tumor (IMT); inflammatory pseudotumor (IPT); differential diagnosis; PLASMA-CELL GRANULOMA; ALK; GENE; LUNG; REARRANGEMENT; EXPRESSION; FUSION; 2P23;
D O I
10.21037/jtd.2017.02.89
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Pulmonary inflammatory myofibroblastic tumor (IMT) has been considered as a synonym for inflammatory pseudotumor (IPT) for a long time. Recent studies have indicated that IMT and I(g)G4-related IPT are distinct diseases. However, no consensus criteria have been recommended. Here we propose a set of criteria for the differential diagnosis. Methods: Twenty-six archived IMT and I(g)G4-related IPT samples were examined for histological characteristics and the expression of I(g)G, I(g)G4, SMA and ALK-1. Based on our proposed criteria, we reclassified the cases into either IMT or IgG4-related IPT group and compared the clinicopathological features, laboratory findings, overall survivals (OS) and disease-free survivals between groups to validate the effectiveness and dependability of the diagnostic criteria. Results: The average age of IgG4-related IPT group was higher than IMTs (48.82 vs. 39.22 years, P= 0.031). In IMT group, tumors were characterized by bigger tumor sizes (3.47 vs. 2.22 cm, P= 0.007), diffuse and total destroyed alveoli (88.89% vs. 17.65%, P= 0.002), fewer lymphoid follicles (1.6/ HPF vs. 3.0/ HPF, P= 0.045) and lower expression of IgG (74.7/ HPF vs. 149.1/ HPF; P < 0.001). As an exclusion criterion of IgG4-related IPT, ALK-positivity was correlated with the higher cytological atypia (mean 3.7/ HPF, P < 0.001) and lesser lymphoid follicles (mean 1.2/ HPF, P= 0.021). And it's the first study to show the liner positive correlation between the lymphocytes + plasma cells count and IgG4-positive plasma cells count in these lesions (r= 0.914, P < 0.001). The negative correlation between the IgG4-positive plasma cells count and the expression of ALK-1 are reported for the first time as well (rs=-0.632, P= 0.001). However, despite two patients with recurrence or metastasis were divided into IMT group, only borderline values were detected in the survival analysis (OS 88.89% vs. 100%, P= 0.197, DFS 77.78% vs. 100.00%; P= 0.056). Conclusions: The significant differences of clinicopathological characteristics between the IMTs and I(g)G4-related IPTs indicated that a combination of lymphocytes + plasma cells count, cytological atypia, IgG4 and ALK-1 staining will be helpful in differential diagnosis.
引用
收藏
页码:598 / 609
页数:12
相关论文
共 50 条
  • [21] Inflammatory Myofibroblastic Tumor in the Thyroid Gland: A Retrospective Case Series Study and Literature Review
    Shi, Ping
    Zhang, Lan
    Shi, Huijing
    Wu, Yanzhao
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (06) : 353 - 365
  • [22] Cardiac Inflammatory Myofibroblastic Tumor Causing Pulmonary Artery Obstruction: A Rare Case Report
    Yildiz, Kaan
    Genc, Halise Zeynep
    Kir, Mustafa
    Unal, Nurettin
    Oto, Oztekin
    Paytoncu, Sebnem
    Yuzuguldu, Resmiye Irmak
    Ozer, Erdener
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (07) : E903 - E906
  • [23] A Case of Recurrent Pulmonary Inflammatory Myofibroblastic Tumor with Aggressive Metastasis after Complete Resection
    Moon, Chae Ho
    Yoon, Jong Ho
    Kang, Geon Wook
    Lee, Seong Hyeon
    Baek, Jeong Su
    Kim, Seo Yun
    Kim, Hye-Ryoun
    Kim, Cheol Hyeon
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 75 (04) : 165 - 169
  • [24] Core Biopsy Diagnosis of ALK Positive Inflammatory Myofibroblastic Tumor of Lung: An Interesting Case
    Sachdev, Ritesh
    Mohapatra, Ishani
    Goel, Shalini
    Ahlawat, Kulbir
    Sharma, Neelam
    TURKISH JOURNAL OF PATHOLOGY, 2020, 36 (02) : 173 - 177
  • [25] Pulmonary Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene
    Sokai, Akihiko
    Enaka, Makiko
    Sokai, Risa
    Mori, Shoichi
    Mori, Shunsuke
    Gunji, Masaharu
    Fujino, Masahiko
    Ito, Masafumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (01) : 93 - 96
  • [26] Pulmonary vascular involvement of IgG4-related disease: Case series with a PRISMA-compliant systemic review
    Zhou, Yong
    Shao, Lingyan
    Ruan, Wenjing
    Jin, Joy
    Xu, Hangdi
    Ying, Kejing
    Wu, Xiaohong
    MEDICINE, 2019, 98 (06)
  • [27] Differential Diagnosis of Inflammatory Myofibroblastic Tumour and Low-grade Myofibroblastic Sarcoma: Two Case Reports with a Literature Review
    Ni, C.
    Xu, Y-Y
    Zhou, S-H
    Wang, S-Q
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (01) : 311 - 320
  • [28] A Rare Case of Pulmonary Cryptococcal Inflammatory Myofibroblastic Tumor Diagnosed by Fine Needle Aspiration Cytology
    Kushner, Yael B.
    Brimo, Fadi
    Schwartzman, Kevin
    Auger, Manon
    DIAGNOSTIC CYTOPATHOLOGY, 2010, 38 (06) : 447 - 451
  • [29] Remission of ALK-negative primary pulmonary inflammatory myofibroblastic tumor on treatment with clarithromycin: A case report and review of the literature
    Watanabe, Hidehiro
    Uruma, Tomonori
    Tazaki, Gen
    Tajiri, Takuma
    Kikuchi, Ryota
    Itoh, Masayuki
    Aoshiba, Kazutetsu
    Nakamura, Hiroyuki
    ONCOLOGY LETTERS, 2016, 11 (03) : 1757 - 1761
  • [30] Pulmonary inflammatory Myofibroblastic tumor indistinguishable from tuberculosis: a case report in a five-year-old child with hemoptysis
    Zuo, Tao
    Fu, Jun
    Ni, Zhengyi
    Chen, Baojun
    JOURNAL OF CARDIOTHORACIC SURGERY, 2017, 12